Your Article Summary
See Latest ArticlesExpression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease
Journal of Immunology, 06/30/09
Andoh A et al. - IL-24 did not modulate the proliferation of HT-29 cells, but significantly increased the mRNA expression of membrane-bound mucins. IL-24 derived from colonic SEMFs acts on colonic epithelial cells to elicit JAK1/STAT-3 activation and the expression of SOCS3 and mucins, supporting their suppressive effects on mucosal inflammation in IBD.
Related Articles
IBD drugs and cancer risk
JAMA, 11/18/09
Relevance Score: 87%
Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09
Relevance Score: 87%
Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences, 10/19/09
Relevance Score: 87%
Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 85%
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Relevance Score: 85%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of appendicectomy in the subsequent development of inflammatory bowel disease: a UK-based study
International Journal of Colorectal Disease, 12/17/09
Delayed Colonic Perforation after ESD in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
The Internet Journal of Gastroenterology, 12/17/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09